Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.31 USD | -5.86% | +0.63% | +49.43% |
Financials (USD)
Sales 2024 * | 551M | Sales 2025 * | 587M | Capitalization | 2.4B |
---|---|---|---|---|---|
Net income 2024 * | -174M | Net income 2025 * | -193M | EV / Sales 2024 * | 3.97 x |
Net cash position 2024 * | 212M | Net Debt 2025 * | 234M | EV / Sales 2025 * | 4.49 x |
P/E ratio 2024 * |
-14
x | P/E ratio 2025 * |
-12.7
x | Employees | 1,453 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.74% |
Latest transcript on NovoCure Limited
1 day | -5.86% | ||
1 week | +0.63% | ||
Current month | +82.27% | ||
1 month | +85.07% | ||
3 months | +46.58% | ||
6 months | +87.16% | ||
Current year | +49.43% |
Managers | Title | Age | Since |
---|---|---|---|
Asaf Danziger
CEO | Chief Executive Officer | 56 | 01-12-31 |
Ashley Cordova
DFI | Director of Finance/CFO | 45 | 14-05-31 |
Moshe Giladi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Doyle
CHM | Chairman | 61 | 03-12-31 |
Kin Yip Leung
BRD | Director/Board Member | 62 | 11-08-04 |
David Hung
BRD | Director/Board Member | 66 | 18-05-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.81% | 0 M€ | 0.00% | - | |
0.71% | 0 M€ | 0.00% | - | |
0.19% | 17 M€ | +7.08% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 22.31 | -5.86% | 1,385,287 |
24-05-22 | 23.7 | +4.18% | 1,426,107 |
24-05-21 | 22.75 | -5.41% | 2,028,086 |
24-05-20 | 24.05 | +9.37% | 2,358,508 |
24-05-17 | 21.99 | -0.81% | 1,150,859 |
Delayed Quote Nasdaq, May 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+49.43% | 2.55B | |
+75.33% | 12.54B | |
-24.19% | 7.71B | |
+6.43% | 6.72B | |
+13.59% | 5.38B | |
+34.82% | 4.89B | |
-15.69% | 4.71B | |
-24.93% | 3.75B | |
-26.93% | 2.77B | |
+0.25% | 2.05B |
- Stock Market
- Equities
- NVCR Stock